Skip to main content
. 2023 Jan 3;5(4):100667. doi: 10.1016/j.jhepr.2022.100667

Table 1.

Prevalence of risk factors for BCS and PVT in the absence of underlying liver disease and proposed diagnostic work-up and specific management (see[4], [5], [6], [7],13,14).

Condition Prevalence
Recommended work-up
BCS PVT
Myeloproliferative neoplasm 30–57% 21–25% Systematic genetic testing of the V617F mutation of the JAK2 gene in all patients.
If negative:
  • - Genetic testing of the CALR gene if platelet count ≥200 ×109/L and/or spleen length ≥16 cm

  • - Discuss next-generation sequencing

  • - Discuss bone marrow biopsy

 JAK2 V617F 2845% 1521%
 CALR mutation 13% 12%
Inherited thrombophilic disorders Genetic testing for prothrombin G202101A and Factor V Leiden mutationsProtein S activity
Protein C activity
Antithrombin activity
Protein S, C and antithrombin activities should be assessed in the absence of VKAs. Cautious interpretation of impaired liver function
 G20210A prothrombin gene mutation 12% 5%
 Factor V Leiden mutation 4% 8%
 Antithrombin deficiency 3% 5%
 Protein C deficiency 2% 1%
 Protein S deficiency 2% 2%
Acquired thrombophilic disorders
 Antiphospholipid antibody syndrome 5% 5% Lupus anticoagulant, anti-cardiolipin, and anti-beta2 glycoprotein 1 antibody testing
Repeat testing after 12 weeks in case of positive testing
 Paroxysmal nocturnal hemoglobinuria 10% 0-0.5% Flow cytometry analysis
 Behcet’s disease 1-2% Uncommon No specific testing, clinical diagnosis
Suspect Behcet's disease if: male sex, Mediterranean origin
IVC stenosis, genital/oral ulcers, deep vein thrombosis in other sites, arterial thrombosis
Coeliac disease 1.4% 0.7% Anti-transglutaminase antibody +/- duodenal biopsies
Other systemic factors
  • Auto-immune disease

  • Inflammatory bowel disease

  • Vasculitis

  • Sarcoidosis

  • Connective tissue disease

  • CMV disease

Search clinical and/or laboratory features
CMV IgM and CMV PCR (blood)
Hormonal factors
  • Oral contraceptive or pregnancy

∼30% ∼20% Clinical context
Search for introduction/modification of oral contraception within 6 months before diagnosis
Local factors
  •  Pancreatitis

  •  Diverticulitis

  •  Cholecystitis

  •  Appendicitis

  •  Intra-abdominal surgery

  •  Hydatid cyst

0-3% 20 % CT scan
Colonoscopy
No identified factor 10-29% 15-40%

BCS, Budd-Chiari syndrome; CMV, cytomegalovirus; IVC, inferior vena cava; PVT, portal vein thrombosis; VKAs, vitamin K antagonists.